Search Results

There are 20605 results for: content related to: Adalimumab therapy for psoriasis in real-world practice: efficacy, safety and results in biologic-naïve vs. non-naïve patients

  1. You have free access to this content
    2016 ACR/ARHP Annual Meeting Abstract Supplement

    Arthritis & Rheumatology

    Volume 68, Issue S10, October 2016, Pages: 1–4550,

    Version of Record online : 8 NOV 2016, DOI: 10.1002/art.39977

  2. Sequential use of biologics in the treatment of moderate-to-severe plaque psoriasis

    British Journal of Dermatology

    Volume 167, Issue s3, November 2012, Pages: 12–20, J. Leman and A.D. Burden

    Version of Record online : 22 OCT 2012, DOI: 10.1111/j.1365-2133.2012.11209.x

  3. Efficacy, safety and medication cost implications of adalimumab 40 mg weekly dosing in patients with psoriasis with suboptimal response to 40 mg every other week dosing: results from an open-label study

    British Journal of Dermatology

    Volume 167, Issue 3, September 2012, Pages: 658–667, C. Leonardi, J.M. Sobell, J.J. Crowley, U. Mrowietz, Y. Bao, P.M. Mulani, Y. Gu and M.M. Okun

    Version of Record online : 20 AUG 2012, DOI: 10.1111/j.1365-2133.2012.11041.x

  4. Adalimumab for the treatment of psoriasis in real life: a retrospective cohort of 119 patients at a single Spanish centre

    British Journal of Dermatology

    Volume 169, Issue 5, November 2013, Pages: 1141–1147, A. López-Ferrer, E. Vilarrasa, I.J. Gich and L. Puig

    Version of Record online : 31 OCT 2013, DOI: 10.1111/bjd.12543

  5. Switching from etanercept to adalimumab is effective and safe: results in 30 patients with psoriasis with primary failure, secondary failure or intolerance to etanercept

    British Journal of Dermatology

    Volume 163, Issue 4, October 2010, Pages: 838–846, P.P.M. Van Lümig, L.L.A. Lecluse, R.J.B. Driessen, P.I. Spuls, J.B. Boezeman, P.C.M. Van De Kerkhof and E.M.G.J. De Jong

    Version of Record online : 22 JUL 2010, DOI: 10.1111/j.1365-2133.2010.09950.x

  6. S3 – Guidelines on the treatment of psoriasis vulgaris (English version). Update

    JDDG: Journal der Deutschen Dermatologischen Gesellschaft

    Volume 10, Issue s2, March 2012, Pages: S1–s95, Alexander Nast, Wolf-Henning Boehncke, Ulrich Mrowietz, Hans-Michael Ockenfels, Sandra Philipp, Kristian Reich, Thomas Rosenbach, Adel Sammain, Martin Schlaeger, Michael Sebastian, Wolfram Sterry, Volker Streit, Matthias Augustin, Ricardo Erdmann, Joachim Klaus, Joachim Koza, Siegrid Muller, Hans-Dieter Orzechowski, Stefanie Rosumeck, Gerhard Schmid-Ott, Tobias Weberschock and Berthold Rzany

    Version of Record online : 5 MAR 2012, DOI: 10.1111/j.1610-0387.2012.07919.x

  7. Efficacy and safety of adalimumab in patients with psoriasis previously treated with anti-tumour necrosis factor agents: subanalysis of BELIEVE

    Journal of the European Academy of Dermatology and Venereology

    Volume 25, Issue 9, September 2011, Pages: 1012–1020, J.-P. Ortonne, S. Chimenti, K. Reich, R. Gniadecki, P. Sprøgel, K. Unnebrink, H. Kupper, O. Goldblum and D. Thaçi

    Version of Record online : 9 JAN 2011, DOI: 10.1111/j.1468-3083.2010.03944.x

  8. Long-term outcomes of interruption and retreatment vs. continuous therapy with adalimumab for psoriasis: subanalysis of REVEAL and the open-label extension study

    Journal of the European Academy of Dermatology and Venereology

    Volume 27, Issue 5, May 2013, Pages: 634–642, K. Papp, A. Menter, Y. Poulin, Y. Gu and E.H. Sasso

    Version of Record online : 16 MAR 2012, DOI: 10.1111/j.1468-3083.2012.04515.x

  9. You have full text access to this OnlineOpen article
    Adalimumab retreatment successfully restores clinical response and health-related quality of life in patients with moderate to severe psoriasis who undergo therapy interruption

    Journal of the European Academy of Dermatology and Venereology

    Volume 29, Issue 4, April 2015, Pages: 767–776, K.B. Gordon, A.B. Gottlieb, R.G. Langely, P. van de Kerkhof, K.T. Belasco, M. Sundaram, M. Okun and L. Serra

    Version of Record online : 3 OCT 2014, DOI: 10.1111/jdv.12677

  10. Efficacy and safety of adalimumab when added to inadequate therapy for the treatment of psoriasis: results of PRIDE, an open-label, multicentre, phase IIIb study

    Journal of the European Academy of Dermatology and Venereology

    Volume 26, Issue 8, August 2012, Pages: 1007–1013, K. Papp, V. Ho, H.D. Teixeira, B. Guerette, K. Chen and C. Lynde

    Version of Record online : 25 OCT 2011, DOI: 10.1111/j.1468-3083.2011.04225.x

  11. Comparison of the 1- and 5-year effectiveness of adalimumab, etanercept and ustekinumab in patients with psoriasis in daily clinical practice: results from the prospective BioCAPTURE registry

    British Journal of Dermatology

    Volume 176, Issue 4, April 2017, Pages: 1001–1009, J. Zweegers, J.M.M. Groenewoud, J.M.P.A. van den Reek, M.E. Otero, P.C.M. van de Kerkhof, R.J.B. Driessen, P.P.M. van Lümig, M.D. Njoo, P.M. Ossenkoppele, J.M. Mommers, M.I.A. Koetsier, W.P. Arnold, M.P.M. Andriessen, A.L.A. Kuijpers, M.A.M. Berends, W. Kievit and E.M.G.J. de Jong

    Version of Record online : 10 MAR 2017, DOI: 10.1111/bjd.15023

  12. You have full text access to this OnlineOpen article
    Safety and efficacy of adalimumab treatment in Japanese patients with psoriasis: Results of SALSA study

    The Journal of Dermatology

    Volume 43, Issue 11, November 2016, Pages: 1257–1266, Akihiko Asahina, Hideshi Torii, Mamitaro Ohtsuki, Toshimitsu Tokimoto, Hidenori Hase, Tsuyoshi Tsuchiya, Yasuhiko Shinmura, Ofelia Reyes Servin and Hidemi Nakagawa

    Version of Record online : 30 APR 2016, DOI: 10.1111/1346-8138.13409

  13. You have free access to this content
    Adalimumab treatment optimization for psoriasis: Results of a long-term phase 2/3 Japanese study

    The Journal of Dermatology

    Volume 42, Issue 11, November 2015, Pages: 1042–1052, Akihiko Asahina, Mamitaro Ohtsuki, Takafumi Etoh, Yihua Gu, Martin M. Okun, Henrique D. Teixeira, Yuji Yamaguchi and Hidemi Nakagawa

    Version of Record online : 29 JUN 2015, DOI: 10.1111/1346-8138.13001

  14. Efficacy of systemic therapies for moderate-to-severe psoriasis: a systematic review and meta-analysis of long-term treatment

    Journal of the European Academy of Dermatology and Venereology

    Volume 26, Issue 11, November 2012, Pages: 1331–1344, T.C. Lucka, D. Pathirana, A. Sammain, F. Bachmann, S. Rosumeck, R. Erdmann, J. Schmitt, H. Orawa, B. Rzany and A. Nast

    Version of Record online : 9 MAR 2012, DOI: 10.1111/j.1468-3083.2012.04492.x

  15. Frequency and predictors of a high clinical response in patients with psoriasis on biological therapy in daily practice: results from the prospective, multicenter BioCAPTURE cohort

    British Journal of Dermatology

    Volume 176, Issue 3, March 2017, Pages: 786–793, J. Zweegers, B. Roosenboom, P.C.M. van de Kerkhof, J.M.P.A. van den Reek, M.E. Otero, S. Atalay, A.L.A. Kuijpers, M.I.A. Koetsier, W.P. Arnold, M.A. Berends, L. Weppner-Parren, M. Bijen, M.D. Njoo, J.M. Mommers, P.P.M. van Lümig, R.J.B. Driessen, W. Kievit and E.M.G.J. de Jong

    Version of Record online : 7 OCT 2016, DOI: 10.1111/bjd.14888

  16. You have free access to this content
    Effective and sustainable biologic treatment of psoriasis: what can we learn from new clinical data?

    Journal of the European Academy of Dermatology and Venereology

    Volume 26, Issue s2, March 2012, Pages: 21–29, R.G. Langley

    Version of Record online : 22 FEB 2012, DOI: 10.1111/j.1468-3083.2011.04412.x

  17. Efficacy and safety results from the randomized controlled comparative study of adalimumab vs. methotrexate vs. placebo in patients with psoriasis (CHAMPION)

    British Journal of Dermatology

    Volume 158, Issue 3, March 2008, Pages: 558–566, J.-H. Saurat, G. Stingl, L. Dubertret, K. Papp, R.G. Langley, J.-P. Ortonne, K. Unnebrink, M. Kaul, A. Camez and for the CHAMPION Study Investigators

    Version of Record online : 28 NOV 2007, DOI: 10.1111/j.1365-2133.2007.08315.x

  18. Adalimumab for the treatment of moderate to severe psoriasis: subanalysis of effects on scalp and nails in the BELIEVE study

    Journal of the European Academy of Dermatology and Venereology

    Volume 29, Issue 2, February 2015, Pages: 353–360, D. Thaçi, K. Unnebrink, M. Sundaram, S. Sood and Y. Yamaguchi

    Version of Record online : 21 MAY 2014, DOI: 10.1111/jdv.12553

  19. The effectiveness and safety of adalimumab in the treatment of non-reimbursed patients with mild-to-moderate psoriasis

    Journal of the European Academy of Dermatology and Venereology

    Volume 26, Issue 8, August 2012, Pages: 991–998, H.-Y. Chiu, T.-S. Wang, C.-Y. Chang and T.-F. Tsai

    Version of Record online : 4 AUG 2011, DOI: 10.1111/j.1468-3083.2011.04199.x

  20. You have free access to this content
    British Association of Dermatologists’ guidelines for biologic interventions for psoriasis 2009

    British Journal of Dermatology

    Volume 161, Issue 5, November 2009, Pages: 987–1019, C.H. Smith, A.V. Anstey, J.N.W.N. Barker, A.D. Burden, R.J.G. Chalmers, D.A. Chandler, A.Y. Finlay, C.E.M. Griffiths, K. Jackson, N.J. McHugh, K.E. McKenna, N.J. Reynolds, A.D. Ormerod and (Chair of Guideline Group)

    Version of Record online : 20 OCT 2009, DOI: 10.1111/j.1365-2133.2009.09505.x